US$ 26.71
is tirzepatide safe for pregnancy Tirzepatide, Birth Control, and GLP-1 Weight-Loss Medications & Fertility
Description
GLP1-RAs have proven non-inferiority the CVD outcomes

however, this combination requires careful consideration and individualised medical guidance
Trial participants reported more frequent side effects, such as nausea, vomiting, and gastrointestinal discomfort, with some experiencing more adverse events

The longer the gap in treatment, the bigger the jump in risk up to a 22% increase for heart attack, stroke and death after two years off GLP-1s, largely erasing the cardiovascular benefits gained during treatment

The gastrointestinal system secretes these hormones following nutrient intake

If you experience any side effects, its important to monitor them and report anything unusual to your doctor
